Back to search

Article

Cyclocreatine suppresses prostate tumorigenesis through dual effects on SAM and creatine metabolism

2021-02-26

Abstract excerpt

<h4>ABSTRACT</h4> Prostate cancer is highly prevalent, being the second most common cause of cancer mortality in men worldwide. Applying a novel genetically engineered mouse model (GEMM) of aggressive prostate cancer driven by deficiency of PTEN and SPRY2 (Sprouty 2) tumour suppressors, we identified enhanced creatine metabolism within the phosphagen system in progressive disease. Altered creatine metabolism was...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b36e5b6b-ce06-5ff8-8b4c-2ebe98f519e6
DOI
10.1101/2021.02.26.432994
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cyclocreatine suppresses prostate tumorigenesis through dual effects on SAM and creatine metabolismDOI 10.1101/2021.02.26.432994
Select a neighboring publication to make it the new centre.